The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 6,499 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 6,379 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 6,235 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 6,436 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 8,315 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 2,981 | 183,000 | SH | SOLE | 183,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 8,512 | 730,000 | SH | SOLE | 730,000 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 3,860 | 830,000 | SH | SOLE | 830,000 | 0 | 0 | ||
| LANNET INC | COM | 516012101 | 3,240 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 8,451 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 2,889 | 1,090,000 | SH | SOLE | 1,090,000 | 0 | 0 | ||
| UTAH MED PRODS INC | COM | 917488108 | 4,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 3,169 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||